ID   S13A3_RAT               Reviewed;         600 AA.
AC   Q9Z0Z5;
DT   19-SEP-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   29-MAY-2024, entry version 122.
DE   RecName: Full=Na(+)/dicarboxylate cotransporter 3;
DE            Short=NaDC-3;
DE            Short=rNaDC3;
DE   AltName: Full=Na(+)-coupled carboxylate transporter 3;
DE            Short=NaC3;
DE   AltName: Full=Sodium-dependent high-affinity dicarboxylate transporter 2 {ECO:0000303|PubMed:10207168};
DE            Short=SDCT2 {ECO:0000303|PubMed:10207168};
DE   AltName: Full=Solute carrier family 13 member 3;
GN   Name=Slc13a3; Synonyms=Nadc3, Sdct2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, FUNCTION, AND TRANSPORT
RP   ACTIVITY.
RC   TISSUE=Placenta;
RX   PubMed=9920886; DOI=10.1074/jbc.274.6.3422;
RA   Kekuda R., Wang H., Huang W., Pajor A.M., Leibach F.H., Devoe L.D.,
RA   Prasad P.D., Ganapathy V.;
RT   "Primary structure and functional characteristics of a mammalian sodium-
RT   coupled high affinity dicarboxylate transporter.";
RL   J. Biol. Chem. 274:3422-3429(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, ACTIVITY REGULATION,
RP   FUNCTION, TRANSPORT ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RC   STRAIN=Sprague-Dawley; TISSUE=Kidney;
RX   PubMed=10207168; DOI=10.1172/jci5392;
RA   Chen X., Tsukaguchi H., Chen X.-Z., Berger U.V., Hediger M.A.;
RT   "Molecular and functional analysis of SDCT2, a novel rat sodium-dependent
RT   dicarboxylate transporter.";
RL   J. Clin. Invest. 103:1159-1168(1999).
RN   [3]
RP   FUNCTION, AND TRANSPORT ACTIVITY.
RC   TISSUE=Placenta;
RX   PubMed=10794676; DOI=10.1152/ajpcell.2000.278.5.c1019;
RA   Wang H., Fei Y.-J., Kekuda R., Yang-Feng T.L., Devoe L.D., Leibach F.H.,
RA   Prasad P.D., Ganapathy V.;
RT   "Structure, function, and genomic organization of human Na(+)-dependent
RT   high-affinity dicarboxylate transporter.";
RL   Am. J. Physiol. 278:C1019-C1030(2000).
RN   [4]
RP   FUNCTION, TRANSPORT ACTIVITY, AND TISSUE SPECIFICITY.
RX   PubMed=10992006;
RA   Huang W., Wang H., Kekuda R., Fei Y.J., Friedrich A., Wang J., Conway S.J.,
RA   Cameron R.S., Leibach F.H., Ganapathy V.;
RT   "Transport of N-acetylaspartate by the Na(+)-dependent high-affinity
RT   dicarboxylate transporter NaDC3 and its relevance to the expression of the
RT   transporter in the brain.";
RL   J. Pharmacol. Exp. Ther. 295:392-403(2000).
RN   [5]
RP   FUNCTION, AND TRANSPORT ACTIVITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=12177002; DOI=10.1074/jbc.m207072200;
RA   Inoue K., Zhuang L., Maddox D.M., Smith S.B., Ganapathy V.;
RT   "Structure, function, and expression pattern of a novel sodium-coupled
RT   citrate transporter (NaCT) cloned from mammalian brain.";
RL   J. Biol. Chem. 277:39469-39476(2002).
CC   -!- FUNCTION: High-affinity sodium-dicarboxylate cotransporter that accepts
CC       a range of substrates with 4-6 carbon atoms, such as the citric acid
CC       cycle intermediates succinate and alpha-ketoglutarate (2-oxoglutarate),
CC       as well as other compounds including N-acetyl-L-aspartate
CC       (PubMed:10207168, PubMed:10794676, PubMed:10992006, PubMed:12177002,
CC       PubMed:9920886). Transports the dicarboxylate into the cell with a
CC       probable stoichiometry of 3 Na(+) for 1 divalent dicarboxylate,
CC       rendering the process electrogenic (PubMed:10207168, PubMed:10992006,
CC       PubMed:9920886). Can transport citrate in a Na(+)-dependent manner,
CC       recognizing the divalent form of citrate rather than the trivalent form
CC       which is normally found in blood (PubMed:10207168).
CC       {ECO:0000269|PubMed:10207168, ECO:0000269|PubMed:10794676,
CC       ECO:0000269|PubMed:10992006, ECO:0000269|PubMed:12177002,
CC       ECO:0000269|PubMed:9920886}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3 Na(+)(out) + succinate(out) = 3 Na(+)(in) + succinate(in);
CC         Xref=Rhea:RHEA:71919, ChEBI:CHEBI:29101, ChEBI:CHEBI:30031;
CC         Evidence={ECO:0000269|PubMed:10207168, ECO:0000269|PubMed:10794676,
CC         ECO:0000269|PubMed:10992006, ECO:0000269|PubMed:12177002,
CC         ECO:0000269|PubMed:9920886};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-oxoglutarate(out) + 3 Na(+)(out) = 2-oxoglutarate(in) + 3
CC         Na(+)(in); Xref=Rhea:RHEA:71939, ChEBI:CHEBI:16810,
CC         ChEBI:CHEBI:29101; Evidence={ECO:0000305|PubMed:9920886};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N-acetyl-L-aspartate(out) + 3 Na(+)(out) = N-acetyl-L-
CC         aspartate(in) + 3 Na(+)(in); Xref=Rhea:RHEA:71947, ChEBI:CHEBI:16953,
CC         ChEBI:CHEBI:29101; Evidence={ECO:0000305|PubMed:10992006};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glutarate(out) + 3 Na(+)(out) = glutarate(in) + 3 Na(+)(in);
CC         Xref=Rhea:RHEA:71955, ChEBI:CHEBI:29101, ChEBI:CHEBI:30921;
CC         Evidence={ECO:0000250|UniProtKB:Q8WWT9};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=fumarate(out) + 3 Na(+)(out) = fumarate(in) + 3 Na(+)(in);
CC         Xref=Rhea:RHEA:71931, ChEBI:CHEBI:29101, ChEBI:CHEBI:29806;
CC         Evidence={ECO:0000250|UniProtKB:Q91Y63};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=malate(out) + 3 Na(+)(out) = malate(in) + 3 Na(+)(in);
CC         Xref=Rhea:RHEA:72295, ChEBI:CHEBI:15595, ChEBI:CHEBI:29101;
CC         Evidence={ECO:0000250|UniProtKB:Q8WWT9};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2,2-dimethylsuccinate(out) + 3 Na(+)(out) = 2,2-
CC         dimethylsuccinate(in) + 3 Na(+)(in); Xref=Rhea:RHEA:72287,
CC         ChEBI:CHEBI:29101, ChEBI:CHEBI:191383;
CC         Evidence={ECO:0000250|UniProtKB:Q8WWT9};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2,3-dimethylsuccinate(out) + 3 Na(+)(out) = 2,3-
CC         dimethylsuccinate(in) + 3 Na(+)(in); Xref=Rhea:RHEA:72291,
CC         ChEBI:CHEBI:29101, ChEBI:CHEBI:191384;
CC         Evidence={ECO:0000250|UniProtKB:Q8WWT9};
CC   -!- ACTIVITY REGULATION: Li(+) decreases succinate transport in the
CC       presence of Na(+). {ECO:0000269|PubMed:10207168}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=15 uM for succinate {ECO:0000269|PubMed:10207168};
CC       pH dependence:
CC         Optimum pH is 7.5. {ECO:0000269|PubMed:10207168,
CC         ECO:0000269|PubMed:9920886};
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Highly expressed in proximal parts of straight
CC       tubules in the kidney (PubMed:10207168, PubMed:9920886). Detected in
CC       placenta, in brain, and in liver (PubMed:9920886). Strongly expressed
CC       within the meningeal layers of supporting tissue that surround the
CC       brain and relatively weakly expressed throughout the cerebral cortex,
CC       hippocampus, and cerebellum (PubMed:10992006).
CC       {ECO:0000269|PubMed:10207168, ECO:0000269|PubMed:10992006,
CC       ECO:0000269|PubMed:9920886}.
CC   -!- SIMILARITY: Belongs to the SLC13A/DASS transporter (TC 2.A.47) family.
CC       NADC subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF081825; AAD16019.1; -; mRNA.
DR   EMBL; AF080451; AAD30657.1; -; mRNA.
DR   AlphaFoldDB; Q9Z0Z5; -.
DR   SMR; Q9Z0Z5; -.
DR   STRING; 10116.ENSRNOP00000025843; -.
DR   TCDB; 2.A.47.1.4; the divalent anion:na(+) symporter (dass) family.
DR   GlyCosmos; Q9Z0Z5; 2 sites, No reported glycans.
DR   GlyGen; Q9Z0Z5; 2 sites.
DR   PhosphoSitePlus; Q9Z0Z5; -.
DR   PaxDb; 10116-ENSRNOP00000025843; -.
DR   Ensembl; ENSRNOT00055005849; ENSRNOP00055004398; ENSRNOG00055003665.
DR   Ensembl; ENSRNOT00060002213; ENSRNOP00060001400; ENSRNOG00060001468.
DR   Ensembl; ENSRNOT00065022520; ENSRNOP00065017473; ENSRNOG00065013665.
DR   UCSC; RGD:628786; rat.
DR   AGR; RGD:628786; -.
DR   RGD; 628786; Slc13a3.
DR   eggNOG; KOG1281; Eukaryota.
DR   InParanoid; Q9Z0Z5; -.
DR   PhylomeDB; Q9Z0Z5; -.
DR   Reactome; R-RNO-433137; Sodium-coupled sulphate, di- and tri-carboxylate transporters.
DR   SABIO-RK; Q9Z0Z5; -.
DR   PRO; PR:Q9Z0Z5; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0016323; C:basolateral plasma membrane; ISO:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0015139; F:alpha-ketoglutarate transmembrane transporter activity; ISO:RGD.
DR   GO; GO:0015137; F:citrate transmembrane transporter activity; IDA:ARUK-UCL.
DR   GO; GO:0005310; F:dicarboxylic acid transmembrane transporter activity; IDA:RGD.
DR   GO; GO:0034634; F:glutathione transmembrane transporter activity; ISO:RGD.
DR   GO; GO:0015362; F:high-affinity sodium:dicarboxylate symporter activity; ISO:RGD.
DR   GO; GO:0015183; F:L-aspartate transmembrane transporter activity; IDA:RGD.
DR   GO; GO:0005343; F:organic acid:sodium symporter activity; IDA:RGD.
DR   GO; GO:0017153; F:sodium:dicarboxylate symporter activity; IDA:RGD.
DR   GO; GO:0015141; F:succinate transmembrane transporter activity; IDA:ARUK-UCL.
DR   GO; GO:0015810; P:aspartate transmembrane transport; IDA:RGD.
DR   GO; GO:0015746; P:citrate transport; IDA:ARUK-UCL.
DR   GO; GO:0006835; P:dicarboxylic acid transport; IDA:RGD.
DR   GO; GO:0034775; P:glutathione transmembrane transport; ISO:RGD.
DR   GO; GO:0071422; P:succinate transmembrane transport; IDA:ARUK-UCL.
DR   GO; GO:0015744; P:succinate transport; IDA:RGD.
DR   CDD; cd01115; SLC13_permease; 1.
DR   InterPro; IPR001898; SLC13A/DASS.
DR   PANTHER; PTHR10283; SOLUTE CARRIER FAMILY 13 MEMBER; 1.
DR   PANTHER; PTHR10283:SF62; SOLUTE CARRIER FAMILY 13 MEMBER 3; 1.
DR   Pfam; PF00939; Na_sulph_symp; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Glycoprotein; Ion transport; Membrane; Reference proteome;
KW   Sodium; Sodium transport; Symport; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN           1..600
FT                   /note="Na(+)/dicarboxylate cotransporter 3"
FT                   /id="PRO_0000172494"
FT   TOPO_DOM        1..16
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        17..37
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        38..55
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        56..76
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        77..82
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        83..103
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        104..137
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        138..158
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        159..229
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        230..250
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        251..278
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        279..299
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        300..336
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        337..357
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        358..372
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        373..393
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        394..422
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   INTRAMEM        423..443
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        444..461
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        462..482
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        483..505
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        506..526
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        527..546
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        547..567
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        568..600
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        584
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        594
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
SQ   SEQUENCE   600 AA;  66099 MW;  35BC6E0885D7AB3B CRC64;
     MAALAALAKK VWSARRLLVL LLVPLALLPI LFALPPKEGR CLYVILLMAV YWCTEALPLS
     VTALLPIILF PFMGILPSSK VCPQYFLDTN FLFLSGLIMA SAIEERNLHR RIALKVLMLV
     GVQPARLILG MMVTTSFLSM WLSNTASTAM MLPIASAILK SLFGQRDTRK DLPREGEDST
     AAVRGNGLRT VPTEMQFLAS SEGGHAEDVE APLELPDDSK EEEHRRNIWK GFLISIPYSA
     SIGGTATLTG TAPNLILLGQ LKSFFPQCDV VNFGSWFIFA FPLMLLFLLV GWLWISFLYG
     GMSWRGWRKK NSKLQDVAED KAKAVIQEEF QNLGPIKFAE QAVFILFCLF AILLFSRDPK
     FIPGWASLFA PGFVSDAVTG VAIVTILFFF PSQKPSLKWW FDFKAPNSET EPLLSWKKAQ
     ETVPWNIILL LGGGFAMAKG CEESGLSAWI GGQLHPLEHV PPLLAVLLIT VVIAFFTEFA
     SNTATIIIFL PVLAELAIRL HVHPLYLMIP GTVSCSYAFM LPVSTPPNSI AFSTGHLLVK
     DMVRTGLLMN LMGVLLLSLA MNTWAQAIFQ LGTFPDWANT HAANVTALPP ALTNNTVQTL
//
